What are the challenges faced by COVID-19 vaccines?

Mohnad Abdalla; Amr Ahmed El-Arabey; Xinyi Jiang

doi:10.1080/14760584.2022.2008245

What are the challenges faced by COVID-19 vaccines?

Expert Rev Vaccines. 2022 Jan;21(1):5-7. doi: 10.1080/14760584.2022.2008245. Epub 2021 Nov 26.

Authors

Mohnad Abdalla¹, Amr Ahmed El-Arabey², Xinyi Jiang¹

Affiliations

¹ Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, PR China.
² Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.

No abstract available

Keywords: COVID-19; T cell; adenovirus vector; lipid nanoparticle; vaccines.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19
COVID-19 Vaccines*
Humans

Substances

COVID-19 Vaccines

Grants and funding

This work was supported by Shandong Provincial Key Research and Development Program (Major Scientific and Technological Innovation Project) (2019JZZY021013) Shandong Provincial Key Research and Development Program (2019GSF108080), Funds for Youth Interdisciplinary and Innovation Research Groups of Shandong University (2020QNQT003) and Shandong University postdoctoral fellowship to Mohnad Abdalla.